Seattle (1)

Anaplastic Large Cell Lymphoma, ALK-Positive (1)

CD30-Positive Neoplastic Cells Present (1)

Systemic Anaplastic Large Cell Lymphoma (1)

Withdrawn (1)

phase 1/phase 2 (1)

University of Washington (1)

National Cancer Institute (NCI) (1)

brentuximab vedotin (1)

ceritinib (1)

laboratory biomarker analysis (1)

pharmacological study (1)

drug (1)

other (1)

Other (1)

Interventional (1)

systemic anaplastic large cell lymphoma

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Withdrawn

Oct 8, 2019